Total Payments
$57,390
2024 Payments
$43,132
Companies
12
Transactions
77
Medicare Patients
985
Medicare Billing
$101,145
Payment Breakdown by Category
Other$44,950 (78.3%)
Travel$9,865 (17.2%)
Food & Beverage$2,101 (3.7%)
Consulting$475.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,950 | 14 | 78.3% |
| Travel and Lodging | $9,865 | 19 | 17.2% |
| Food and Beverage | $2,101 | 43 | 3.7% |
| Consulting Fee | $475.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $56,846 | 60 | $0 (2024) |
| Covidien LP | $109.01 | 3 | $0 (2019) |
| CONMED Corporation | $103.56 | 1 | $0 (2018) |
| Shire North American Group Inc | $103.40 | 1 | $0 (2019) |
| Medtronic, Inc. | $81.44 | 3 | $0 (2024) |
| QOL Medical, LLC | $31.96 | 2 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $29.91 | 2 | $0 (2019) |
| Olympus America Inc. | $28.62 | 1 | $0 (2018) |
| UCB, Inc. | $15.09 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $14.32 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,132 | 48 | ABBVIE INC. ($43,077) |
| 2023 | $13,757 | 13 | AbbVie Inc. ($13,730) |
| 2021 | $13.52 | 1 | Axonics, Inc. ($13.52) |
| 2019 | $300.87 | 9 | Covidien LP ($109.01) |
| 2018 | $174.99 | 5 | CONMED Corporation ($103.56) |
| 2017 | $11.96 | 1 | Intercept Pharmaceuticals, Inc. ($11.96) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $56.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $76.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $1,668.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $126.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $89.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $1,035.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $1,155.60 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $51.81 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | Medtronic, Inc. | MANOSCAN (Device) | Food and Beverage | In-kind items and services | $36.76 | General |
| Category: Motility Testing | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| 07/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $534.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $534.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $198.08 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $198.08 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 243 | 251 | $239,703 | $24,266 |
| 2022 | 9 | 205 | 212 | $224,075 | $21,740 |
| 2021 | 8 | 225 | 234 | $258,922 | $25,130 |
| 2020 | 11 | 312 | 356 | $242,029 | $30,009 |
Total Patients
985
Total Services
1,053
Medicare Billing
$101,145
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 37 | $69,011 | $7,220 | 10.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $44,931 | $2,849 | 6.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 30 | 30 | $40,657 | $2,712 | 6.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $20,696 | $2,119 | 10.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $14,472 | $1,926 | 13.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $18,382 | $1,385 | 7.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,085 | $1,199 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 19 | $3,264 | $1,154 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 21 | $6,225 | $1,091 | 17.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 17 | $4,361 | $1,084 | 24.9% |
| 91122 | Study of rectum sensitivity and function | Facility | 2023 | 17 | 17 | $10,489 | $820.49 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $3,130 | $708.12 | 22.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $62,982 | $6,137 | 9.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $48,504 | $3,433 | 7.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 28 | 29 | $40,576 | $2,636 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 33 | $9,427 | $2,232 | 23.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $23,612 | $2,152 | 9.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $19,359 | $1,619 | 8.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $5,366 | $1,350 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $4,994 | $1,155 | 23.1% |
| 91122 | Study of rectum sensitivity and function | Facility | 2022 | 15 | 15 | $9,255 | $1,025 | 11.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 40 | 40 | $89,298 | $7,940 | 8.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 40 | $47,505 | $3,541 | 7.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 30 | 30 | $42,016 | $3,445 | 8.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 36 | 42 | $11,210 | $3,084 | 27.5% |
About Dr. Jessica Mckee, D.O
Dr. Jessica Mckee, D.O is a Internal Medicine healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1598057150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessica Mckee, D.O has received a total of $57,390 in payments from pharmaceutical and medical device companies, with $43,132 received in 2024. These payments were reported across 77 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,950).
As a Medicare-enrolled provider, Mckee has provided services to 985 Medicare beneficiaries, totaling 1,053 services with total Medicare billing of $101,145. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Danville, PA
- Active Since 05/13/2011
- Last Updated 08/12/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598057150
Products in Payments
- SKYRIZI (Biological) $36,247
- RINVOQ (Biological) $20,048
- CONMED Biliary (Device) $103.56
- GATTEX (Drug) $103.40
- Barrx (Device) $68.11
- MANOSCAN (Device) $63.23
- Sucraid (Drug) $31.96
- Olympus Biliary Devices (Device) $28.62
- Mavyret (Drug) $22.33
- HET (Device) $18.21
- OCALIVA (Drug) $17.95
- Humira (Biological) $16.22
- Cimzia (Drug) $15.09
- Axonics r-SNM System (Device) $13.52
- XIFAXANIBSD (Drug) $13.40
- LINZESS (Drug) $12.67
- OCA (Drug) $11.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Internal Medicine $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Internal Medicine $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Internal Medicine $188,555
Michael Caplan, Md, MD
Internal Medicine — Payments: $41,374
Internal Medicine $41,374
Dr. Mark Reginato, M.d, M.D
Internal Medicine — Payments: $23,997
Internal Medicine $23,997
Mobasser Mahmood, M.d, M.D
Internal Medicine — Payments: $23,322
Internal Medicine $23,322